PRKCD and adrenal cortex carcinoma: Additionally, high PRKCD enhanced patients’ survival rate with ACC, BLCA, LUAD, and UVM but worsened patients’ survival with KIRC, LAML, LGG, LIHC, PRAD READ, STAD, and THCA.